A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 30, 2017

Primary Completion Date

July 3, 2019

Study Completion Date

July 3, 2019

Conditions
Small Cell Lung Cancer
Interventions
DRUG

Ipilimumab

Administered by intravenous infusion

DRUG

Nivolumab

Administered by intravenous infusion

DRUG

Rovalpituzumab tesirine

Administered by intravenous infusion

Trial Locations (35)

13005

Hopital La Timone /ID# 165171, Marseille

20089

Istituto Clinico Humanitas /ID# 165176, Rozzano

20141

Istituto Europeo di Oncologia /ID# 165175, Milan

22927

Lungen Clinic Grosshansdorf /ID# 165182, Großhansdorf

23230

Virginia Cancer Institute /ID# 161025, Richmond

25000

CHU de Besancon - Jean Minjoz /ID# 165173, Besançon

28007

Hospital Genl Gregorio Maranon /ID# 165162, Madrid

28040

Hospital Universitario Fundacion Jimenez Diaz /ID# 165164, Madrid

28050

Hospital Universitario Madrid /ID# 165163, Madrid

29425

Medical University of South Carolina /ID# 161007, Charleston

29609

CHRU de Brest - Hospital Morva /ID# 165170, Brest

30607

University Cancer & Blood Cent /ID# 161028, Athens

31008

Clinica Universitar de Navarra - Pamplona /ID# 165165, Pamplona

32803

Florida Hospital /ID# 161017, Orlando

33081

Centro di Riferimento Oncologi /ID# 165174, Aviano

34376

Lungenfachklinik Immenhausen /ID# 165181, Immenhausen

37203

Tennessee Oncology, PLLC /ID# 161012, Nashville

41100

AO Univ di Modena /ID# 165177, Modena

53705

University of Wisconsin Clinic /ID# 161013, Madison

59020

Centre Oscar Lambret /ID# 165169, Lille

63110

Washington University-School of Medicine /ID# 161011, St Louis

66205

The University of Kansas Clini /ID# 162915, Fairway

82131

Asklepios Fachkliniken M. Gaut /ID# 165183, Gauting

84082

Institut Sainte Catherine /ID# 165172, Avignon

92093

Ucsd /Id# 161030, La Jolla

94800

Institut Gustave Roussy /ID# 165168, Villejuif

95123

Azienda Ospedaliero Universitaria Policlinico Vittorio Emanuele /ID# 165178, Catania

97239

Oregon Health and Science University /ID# 161029, Portland

60637-1443

University of Chicago /ID# 161006, Chicago

08903

Rutgers Cancer Institute of NJ /ID# 161032, New Brunswick

10065-6007

Memorial Sloan Kettering Cancer Center /ID# 161010, New York

27710-3000

Duke University Medical Center /ID# 161009, Durham

37232-6307

Vanderbilt University Med Ctr /ID# 162916, Nashville

06120

KH Martha-Maria Halle Dolau /ID# 165180, Halle

08028

Hosp Univ Quiron Dexues /ID# 165166, Barcelona

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

AbbVie

INDUSTRY